Transposable elements shape stemness in normal and leukemic hematopoiesis
Scientists identified genetic switches controlling leukemia stem cell survival, revealing new potential targets to prevent cancer relapse.
This Nature Genetics study identifies transposable elements (TEs) as key genetic determinants of AML leukemia stem cell (LSC) stemness, showing that 121 TE subfamilies stratify patient survival and that LTR12C elements maintain LSC identity through LYL1 transcription factor docking. Chromatin editing experiments confirm LTR12C necessity for LSC stemness, revealing a novel therapeutic vulnerability linked to AML relapse biology.
What the study was
- Study design
- Multi-omic analysis of chromatin accessibility in human AML LSCs and HSCs with functional validation
- Population
- Human AML patient-derived leukemia stem cells and normal hematopoietic cells
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Nature Genetics
Why it surfaced
Nature Genetics publication with novel mechanistic insight into AML relapse biology via transposable element chromatin regulation of LSC stemness. Functional validation using chromatin editing strengthens causal claims. Translational readiness is exploratory but the patient survival stratification angle suggests potential biomarker utility.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.